WHTCF (WELL Health Technologies) ROCE %: 2.98% (As of Mar. 2026)


WHTCF WELL Health Technologies Corp WHTCF
76 GF Score
Price $2.91
GF Value $5.16
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is WELL Health Technologies ROCE %?

WELL Health Technologies WHTCF 76 ROCE % is 2.98% as of Mar. 2026. GuruFocus rates WHTCF with a GF Score™ of 76/100 and a GF Value™ of $5.16 (Possible Value Trap). The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. WELL Health Technologies's annualized ROCE % for the quarter that ended in Mar. 2026 was 2.98%.

WELL Health Technologies  (OTCPK:WHTCF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

WELL Health Technologies ROCE % Related Terms

WELL Health Technologies ROCE % Historical Data

* Premium members only.

The historical data trend for WELL Health Technologies's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

WELL Health Technologies ROCE % Chart

WELL Health Technologies Annual Data
Trend Oct16 Oct17 Oct18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.41 3.48 4.19 3.23 3.96

WELL Health Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.89 9.44 5.53 8.40 2.98
WHTCF
76GF Score
WELL Health Technologies Corp WHTCF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

WELL Health Technologies ROCE % Calculation

WELL Health Technologies's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=44.789/( ( (1268.529 - 268.18) + (1520.035 - 259.127) )/ 2 )
=44.789/( (1000.349+1260.908)/ 2 )
=44.789/1130.6285
=3.96 %

WELL Health Technologies's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=37.364/( ( (1520.035 - 259.127) + (1578.708 - 333.77) )/ 2 )
=37.364/( ( 1260.908 + 1244.938 )/ 2 )
=37.364/1252.923
=2.98 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 2.98% mean?
WELL Health Technologies (WHTCF) has a ROCE % of 2.98% as of Mar. 2026.
Is WELL Health Technologies' ROCE % too high?
WELL Health Technologies' current ROCE % is 2.98%. The Healthcare Providers & Services industry median ROCE % is 6.41. WELL Health Technologies' value of 2.98% is 53.5% below this industry median. Overall, WELL Health Technologies has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does WELL Health Technologies' ROCE % compare to HCA and THC?
WELL Health Technologies' ROCE % of 2.98% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. WELL Health Technologies' value of 2.98% is 53.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 648 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. WELL Health Technologies's current ROCE % of 2.98% is 53.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. WELL Health Technologies's current ROCE % is 2.98%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WELL Health Technologies stock overvalued right now?
Based on GuruFocus' analysis, WELL Health Technologies (WHTCF) is currently considered Possible Value Trap. The stock's GF Value™ is $5.16, compared to a current price of $2.91 — trading 43.6% below its estimated fair value. The current ROCE % is 2.98% and 53.5% below the Healthcare Providers & Services industry median of 6.41. WELL Health Technologies' overall GF Score™ is 76/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For WELL Health Technologies (WHTCF), the current ROCE % is 2.98% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is WELL Health Technologies (WHTCF) Overvalued in 2026?

Based on GuruFocus' analysis, WELL Health Technologies stock appears to be undervalued. The current stock price of $2.91 is trading 43.6% below its estimated GF Value™ of $5.16. GuruFocus considers WELL Health Technologies to be Possible Value Trap.

Key valuation signals for WHTCF:

  • ROCE %: 2.98%
  • GF Value™: $5.16 vs. price of $2.91 (43.6% below fair value)
  • GF Score™: 76/100 with 6 warning signs
  • Industry Position: 53.5% below the Healthcare Providers & Services median

No single metric tells the full story. See the WHTCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

WELL Health Technologies Business Description

Other Exchanges W7V:GermanyWELL:Canada
Address 375 Water Street, Suite 550, Vancouver, BC, CAN, V6B 5C6
WELL Health Technologies Corp is a practitioner-focused digital healthcare company. It has seven reportable segments that are grouped into three key business units: Canadian Patient Services that includes Primary and Specialized MyHealth; WELL Health USA Patient Services, which derives maximum revenue, includes Primary Circle Medica, Primary WISP, Specialized CRH Medical, and Specialized Provider Staffing; SaaS and Technology Services provides digital health and infrastructure solutions for healthcare providers, including Electronic MedicalRecords (EMRs), patient engagement and eReferral solutions, AI-enabled applications, billing and practice management services, and cybersecurity protection and data privacy solutions; and HEALWELL: AI and data sciences and healthcare software offerings.
76GF Score

Get the complete analysis for WHTCF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.91
Price
$5.16
GF Value